APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

In-Vitro Diagnostics

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

Selected research

Market Structure

Global In-Vitro Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173894520325 December 2025196 pages

Choose your research edition.

Industry ResearchIn-Vitro Diagnostics Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal In-Vitro Diagnostics Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal In-Vitro Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal In-Vitro Diagnostics Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal In-Vitro Diagnostics Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report， we counted In-Vitro Diagnostics reagent.

The concentration of the market is relatively high, and the first 16 companies include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, JNJ, Sysmex, KHB, DaAn Gene, Leadman, BioSino, BSBE and Maccura, they occupied more than 66% of whole market. US dominates the market which occupied 43% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 7% of the whole market.

Report Includes

Read the full market overview

This report provides an overview of the global In-Vitro Diagnostics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In-Vitro Diagnostics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In-Vitro Diagnostics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In-Vitro Diagnostics market size, projected growth trends, production technologies, key applications, and end-use industries.

In-Vitro Diagnostics Segment by Company

Roche

Siemens

Abbott

Danaher

Thermo Fisher

BioMerieux

Bio-Rad

BD

JNJ

Sysmex

KHB

DaAn Gene

Leadman

BioSino

BSBE

Maccura

In-Vitro Diagnostics Segment by Type

Tissue Diagnostics

Professional Diagnostic

Molecular Diagnostic

Diabetes Monitoring

Other

In-Vitro Diagnostics Segment by Application

Diabetes

Infectious Diseases

Oncology

Cardiology

HIV

Other

In-Vitro Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In-Vitro Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In-Vitro Diagnostics industry.

Chapter 3: Detailed analysis of In-Vitro Diagnostics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Diagnosticsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In-Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tissue Diagnostics Table 3. Key Players of Professional Diagnostic Table 4. Key Players of Molecular Diagnostic Table 3. Key Players of Diabetes Monitoring Table 4. Key Players of Other Table 5. Global In-Vitro Diagnostics Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Diabetes Table 7. Key Players of Infectious Diseases Table 8. Key Players of Oncology Table 9. Key Players of Cardiology Table 10. Key Players of HIV Table 11. Key Players of Other Table 12. Global In-Vitro Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global In-Vitro Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 14. Global In-Vitro Diagnostics Market Share by Region (2021-2026) Table 15. Global In-Vitro Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 16. Global In-Vitro Diagnostics Market Share by Region (2027-2032) Table 17. In-Vitro Diagnostics Industry Trends Table 18. In-Vitro Diagnostics Industry Drivers Table 19. In-Vitro Diagnostics Industry Opportunities and Challenges Table 20. In-Vitro Diagnostics Industry Restraints Table 21. Global In-Vitro Diagnostics Revenue by Company (US$ Million) & (2021-2026) Table 22. Global In-Vitro Diagnostics Revenue Market Share by Company (2021-2026) Table 23. Global In-Vitro Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 24. Global In-Vitro Diagnostics Key Company Head Office and Area Served Table 25. Global In-Vitro Diagnostics Company, Product Type & Application Table 26. Global In-Vitro Diagnostics Company Establishment Date Table 27. Global Company Market Concentration Ratio (CR5 and HHI) Table 28. Global In-Vitro Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 29. Global In-Vitro Diagnostics Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 31. Global In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 32. Global In-Vitro Diagnostics Revenue Market Share by Type (2021-2026) Table 33. Global In-Vitro Diagnostics Revenue Market Share by Type (2027-2032) Table 34. Global In-Vitro Diagnostics Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 36. Global In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 37. Global In-Vitro Diagnostics Revenue Market Share by Application (2021-2026) Table 38. Global In-Vitro Diagnostics Revenue Market Share by Application (2027-2032) Table 39. Roche Company Information Table 40. Roche Business Overview Table 41. Roche In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Roche In-Vitro Diagnostics Product Portfolio Table 43. Roche Recent Development Table 44. Siemens Company Information Table 45. Siemens Business Overview Table 46. Siemens In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Siemens In-Vitro Diagnostics Product Portfolio Table 48. Siemens Recent Development Table 49. Abbott Company Information Table 50. Abbott Business Overview Table 51. Abbott In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Abbott In-Vitro Diagnostics Product Portfolio Table 53. Abbott Recent Development Table 54. Danaher Company Information Table 55. Danaher Business Overview Table 56. Danaher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Danaher In-Vitro Diagnostics Product Portfolio Table 58. Danaher Recent Development Table 59. Thermo Fisher Company Information Table 60. Thermo Fisher Business Overview Table 61. Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Thermo Fisher In-Vitro Diagnostics Product Portfolio Table 63. Thermo Fisher Recent Development Table 64. BioMerieux Company Information Table 65. BioMerieux Business Overview Table 66. BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. BioMerieux In-Vitro Diagnostics Product Portfolio Table 68. BioMerieux Recent Development Table 69. Bio-Rad Company Information Table 70. Bio-Rad Business Overview Table 71. Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Bio-Rad In-Vitro Diagnostics Product Portfolio Table 73. Bio-Rad Recent Development Table 74. BD Company Information Table 75. BD Business Overview Table 76. BD In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. BD In-Vitro Diagnostics Product Portfolio Table 78. BD Recent Development Table 79. JNJ Company Information Table 80. JNJ Business Overview Table 81. JNJ In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. JNJ In-Vitro Diagnostics Product Portfolio Table 83. JNJ Recent Development Table 84. Sysmex Company Information Table 85. Sysmex Business Overview Table 86. Sysmex In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Sysmex In-Vitro Diagnostics Product Portfolio Table 88. Sysmex Recent Development Table 89. KHB Company Information Table 90. KHB Business Overview Table 91. KHB In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. KHB In-Vitro Diagnostics Product Portfolio Table 93. KHB Recent Development Table 94. DaAn Gene Company Information Table 95. DaAn Gene Business Overview Table 96. DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. DaAn Gene In-Vitro Diagnostics Product Portfolio Table 98. DaAn Gene Recent Development Table 99. Leadman Company Information Table 100. Leadman Business Overview Table 101. Leadman In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Leadman In-Vitro Diagnostics Product Portfolio Table 103. Leadman Recent Development Table 104. BioSino Company Information Table 105. BioSino Business Overview Table 106. BioSino In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. BioSino In-Vitro Diagnostics Product Portfolio Table 108. BioSino Recent Development Table 109. BSBE Company Information Table 110. BSBE Business Overview Table 111. BSBE In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. BSBE In-Vitro Diagnostics Product Portfolio Table 113. BSBE Recent Development Table 114. Maccura Company Information Table 115. Maccura Business Overview Table 116. Maccura In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. Maccura In-Vitro Diagnostics Product Portfolio Table 118. Maccura Recent Development Table 119. North America In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 120. North America In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 121. North America In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 122. North America In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 123. North America In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. North America In-Vitro Diagnostics Market Size by Country (2021-2026) Table 125. North America In-Vitro Diagnostics Market Size by Country (2027-2032) Table 126. Europe In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 127. Europe In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 128. Europe In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 129. Europe In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 130. Europe In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe In-Vitro Diagnostics Market Size by Country (2021-2026) Table 132. Europe In-Vitro Diagnostics Market Size by Country (2027-2032) Table 133. China In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 134. China In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 135. China In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 136. China In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 137. Asia In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 138. Asia In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 139. Asia In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 140. Asia In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 141. Asia In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Asia In-Vitro Diagnostics Market Size by Country (2021-2026) Table 143. Asia In-Vitro Diagnostics Market Size by Country (2027-2032) Table 144. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Type (2021-2026) & (US$ Million) Table 145. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Type (2027-2032) & (US$ Million) Table 146. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Application (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Application (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 149. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021-2026) Table 150. South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2027-2032) Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. In-Vitro Diagnostics Product Image Figure 2. Global In-Vitro Diagnostics Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global In-Vitro Diagnostics Market Share by Type: 2025 VS 2032 Figure 4. Tissue Diagnostics Image Figure 5. Professional Diagnostic Image Figure 6. Molecular Diagnostic Image Figure 7. Diabetes Monitoring Image Figure 8. Other Image Figure 9. Global In-Vitro Diagnostics Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global In-Vitro Diagnostics Market Share by Application: 2025 VS 2032 Figure 11. Diabetes Image Figure 12. Infectious Diseases Image Figure 13. Oncology Image Figure 14. Cardiology Image Figure 15. HIV Image Figure 16. Other Image Figure 17. Global In-Vitro Diagnostics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 19. Global In-Vitro Diagnostics Market Share by Region: 2025 VS 2032 Figure 20. Years Considered Figure 21. Global In-Vitro Diagnostics Market Share by Players in 2025 Figure 22. Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2025 Figure 23. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. Global In-Vitro Diagnostics Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global In-Vitro Diagnostics Revenue Market Share by Type (2021-2032) Figure 26. Global In-Vitro Diagnostics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global In-Vitro Diagnostics Revenue Market Share by Application (2021-2032) Figure 28. North America In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 29. North America In-Vitro Diagnostics Market Share by Type (2021-2032) Figure 30. North America In-Vitro Diagnostics Market Share by Application (2021-2032) Figure 31. North America In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 32. United States In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 33. Canada In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 34. Mexico In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 35. Europe In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 36. Europe In-Vitro Diagnostics Market Share by Type (2021-2032) Figure 37. Europe In-Vitro Diagnostics Market Share by Application (2021-2032) Figure 38. Europe In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 39. Germany In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 40. France In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 41. U.K. In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 42. Italy In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 43. Russia In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 44. Nordic Countries In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 45. China In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 46. China In-Vitro Diagnostics Market Share by Type (2021-2032) Figure 47. China In-Vitro Diagnostics Market Share by Application (2021-2032) Figure 48. Asia In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 49. Asia In-Vitro Diagnostics Market Share by Type (2021-2032) Figure 50. Asia In-Vitro Diagnostics Market Share by Application (2021-2032) Figure 51. Asia In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 52. Japan In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 53. South Korea In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 54. Taiwan In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 55. Southeast Asia In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 56. India In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 57. Australia In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 58. South America, Middle East & Africa In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 59. South America, Middle East & Africa In-Vitro Diagnostics Market Share by Type (2021-2032) Figure 60. South America, Middle East & Africa In-Vitro Diagnostics Market Share by Application (2021-2032) Figure 61. South America, Middle East & Africa In-Vitro Diagnostics Market Share by Country (2021-2032) Figure 62. Brazil In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 63. South Africa In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 64. Saudi Arabia In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 65. Turkey In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 66. Argentina In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 67. UAE In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 68. Egypt In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 69. Chile In-Vitro Diagnostics Market Size (2021-2032) & (US$ Million) Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tissue Diagnostics
  • Professional Diagnostic
  • Molecular Diagnostic
  • Diabetes Monitoring
  • Other
Applications
  • Diabetes
  • Infectious Diseases
  • Oncology
  • Cardiology
  • HIV
  • Other
Companies covered
  • Roche
  • Siemens
  • Abbott
  • Danaher
  • Thermo Fisher
  • BioMerieux
  • Bio-Rad
  • BD
  • JNJ
  • Sysmex
  • KHB
  • DaAn Gene
  • Leadman
  • BioSino
  • BSBE
  • Maccura

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global In-Vitro Diagnostics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tissue Diagnostics
  5. 1.2.3 Professional Diagnostic
  6. 1.2.4 Molecular Diagnostic
  7. 1.2.5 Diabetes Monitoring
  8. 1.2.6 Other
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global In-Vitro Diagnostics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Diabetes
  12. 1.3.3 Infectious Diseases
  13. 1.3.4 Oncology
  14. 1.3.5 Cardiology
  15. 1.3.6 HIV
  16. 1.3.7 Other
  17. 1.4 Global Market Growth Prospects
  18. 1.5 Global In-Vitro Diagnostics Growth Trends by Region
  19. 1.5.1 Global In-Vitro Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  20. 1.5.2 In-Vitro Diagnostics Market Size by Region (2021-2026)
  21. 1.5.3 In-Vitro Diagnostics Market Size by Region (2027-2032)
  22. 1.6 Assumptions and Limitations
  23. 1.7 Study Goals and Objectives
  24. 1.8 Years Considered
2 Global In-Vitro Diagnostics Market Dynamics
  1. 2.1 In-Vitro Diagnostics Industry Trends
  2. 2.2 In-Vitro Diagnostics Industry Drivers
  3. 2.3 In-Vitro Diagnostics Industry Opportunities and Challenges
  4. 2.4 In-Vitro Diagnostics Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global In-Vitro Diagnostics Revenue by Company (2021-2026)
  2. 3.2 Global In-Vitro Diagnostics Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global In-Vitro Diagnostics Key Company Head office and Area Served
  4. 3.4 Global In-Vitro Diagnostics Company, Product Type & Application
  5. 3.5 Global In-Vitro Diagnostics Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global In-Vitro Diagnostics Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 In-Vitro Diagnostics Players Market Share by Revenue in 2025
  9. 3.6.3 2025 In-Vitro Diagnostics Tier 1, Tier 2, and Tier 3
4 In-Vitro Diagnostics Market by Type
  1. 4.1 Global In-Vitro Diagnostics Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global In-Vitro Diagnostics Market Size by Type (2021-2032)
  3. 4.3 Global In-Vitro Diagnostics Market Size Share by Type (2021-2032)
5 In-Vitro Diagnostics Market by Application
  1. 5.1 Global In-Vitro Diagnostics Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global In-Vitro Diagnostics Market Size by Application (2021-2032)
  3. 5.3 Global In-Vitro Diagnostics Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche In-Vitro Diagnostics Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Siemens
  8. 6.2.1 Siemens Company Information
  9. 6.2.2 Siemens Business Overview
  10. 6.2.3 Siemens In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Siemens In-Vitro Diagnostics Product Portfolio
  12. 6.2.5 Siemens Recent Developments
  13. 6.3 Abbott
  14. 6.3.1 Abbott Company Information
  15. 6.3.2 Abbott Business Overview
  16. 6.3.3 Abbott In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Abbott In-Vitro Diagnostics Product Portfolio
  18. 6.3.5 Abbott Recent Developments
  19. 6.4 Danaher
  20. 6.4.1 Danaher Company Information
  21. 6.4.2 Danaher Business Overview
  22. 6.4.3 Danaher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Danaher In-Vitro Diagnostics Product Portfolio
  24. 6.4.5 Danaher Recent Developments
  25. 6.5 Thermo Fisher
  26. 6.5.1 Thermo Fisher Company Information
  27. 6.5.2 Thermo Fisher Business Overview
  28. 6.5.3 Thermo Fisher In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Thermo Fisher In-Vitro Diagnostics Product Portfolio
  30. 6.5.5 Thermo Fisher Recent Developments
  31. 6.6 BioMerieux
  32. 6.6.1 BioMerieux Company Information
  33. 6.6.2 BioMerieux Business Overview
  34. 6.6.3 BioMerieux In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 BioMerieux In-Vitro Diagnostics Product Portfolio
  36. 6.6.5 BioMerieux Recent Developments
  37. 6.7 Bio-Rad
  38. 6.7.1 Bio-Rad Company Information
  39. 6.7.2 Bio-Rad Business Overview
  40. 6.7.3 Bio-Rad In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Bio-Rad In-Vitro Diagnostics Product Portfolio
  42. 6.7.5 Bio-Rad Recent Developments
  43. 6.8 BD
  44. 6.8.1 BD Company Information
  45. 6.8.2 BD Business Overview
  46. 6.8.3 BD In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 BD In-Vitro Diagnostics Product Portfolio
  48. 6.8.5 BD Recent Developments
  49. 6.9 JNJ
  50. 6.9.1 JNJ Company Information
  51. 6.9.2 JNJ Business Overview
  52. 6.9.3 JNJ In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 JNJ In-Vitro Diagnostics Product Portfolio
  54. 6.9.5 JNJ Recent Developments
  55. 6.10 Sysmex
  56. 6.10.1 Sysmex Company Information
  57. 6.10.2 Sysmex Business Overview
  58. 6.10.3 Sysmex In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Sysmex In-Vitro Diagnostics Product Portfolio
  60. 6.10.5 Sysmex Recent Developments
  61. 6.11 KHB
  62. 6.11.1 KHB Company Information
  63. 6.11.2 KHB Business Overview
  64. 6.11.3 KHB In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 KHB In-Vitro Diagnostics Product Portfolio
  66. 6.11.5 KHB Recent Developments
  67. 6.12 DaAn Gene
  68. 6.12.1 DaAn Gene Company Information
  69. 6.12.2 DaAn Gene Business Overview
  70. 6.12.3 DaAn Gene In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 DaAn Gene In-Vitro Diagnostics Product Portfolio
  72. 6.12.5 DaAn Gene Recent Developments
  73. 6.13 Leadman
  74. 6.13.1 Leadman Company Information
  75. 6.13.2 Leadman Business Overview
  76. 6.13.3 Leadman In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Leadman In-Vitro Diagnostics Product Portfolio
  78. 6.13.5 Leadman Recent Developments
  79. 6.14 BioSino
  80. 6.14.1 BioSino Company Information
  81. 6.14.2 BioSino Business Overview
  82. 6.14.3 BioSino In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 BioSino In-Vitro Diagnostics Product Portfolio
  84. 6.14.5 BioSino Recent Developments
  85. 6.15 BSBE
  86. 6.15.1 BSBE Company Information
  87. 6.15.2 BSBE Business Overview
  88. 6.15.3 BSBE In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BSBE In-Vitro Diagnostics Product Portfolio
  90. 6.15.5 BSBE Recent Developments
  91. 6.16 Maccura
  92. 6.16.1 Maccura Company Information
  93. 6.16.2 Maccura Business Overview
  94. 6.16.3 Maccura In-Vitro Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Maccura In-Vitro Diagnostics Product Portfolio
  96. 6.16.5 Maccura Recent Developments
7 North America
  1. 7.1 North America In-Vitro Diagnostics Market Size (2021-2032)
  2. 7.2 North America In-Vitro Diagnostics Market Size by Type
  3. 7.2.1 North America In-Vitro Diagnostics Market Size by Type (2021-2026)
  4. 7.2.2 North America In-Vitro Diagnostics Market Size by Type (2027-2032)
  5. 7.2.3 North America In-Vitro Diagnostics Market Share by Type (2021-2032)
  6. 7.3 North America In-Vitro Diagnostics Market Size by Application
  7. 7.3.1 North America In-Vitro Diagnostics Market Size by Application (2021-2026)
  8. 7.3.2 North America In-Vitro Diagnostics Market Size by Application (2027-2032)
  9. 7.3.3 North America In-Vitro Diagnostics Market Share by Application (2021-2032)
  10. 7.4 North America In-Vitro Diagnostics Market Size by Country
  11. 7.4.1 North America In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America In-Vitro Diagnostics Market Size by Country (2021-2026)
  13. 7.4.3 North America In-Vitro Diagnostics Market Size by Country (2027-2032)
  14. 7.4.4 North America In-Vitro Diagnostics Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe In-Vitro Diagnostics Market Size (2021-2032)
  2. 8.2 Europe In-Vitro Diagnostics Market Size by Type
  3. 8.2.1 Europe In-Vitro Diagnostics Market Size by Type (2021-2026)
  4. 8.2.2 Europe In-Vitro Diagnostics Market Size by Type (2027-2032)
  5. 8.2.3 Europe In-Vitro Diagnostics Market Share by Type (2021-2032)
  6. 8.3 Europe In-Vitro Diagnostics Market Size by Application
  7. 8.3.1 Europe In-Vitro Diagnostics Market Size by Application (2021-2026)
  8. 8.3.2 Europe In-Vitro Diagnostics Market Size by Application (2027-2032)
  9. 8.3.3 Europe In-Vitro Diagnostics Market Share by Application (2021-2032)
  10. 8.4 Europe In-Vitro Diagnostics Market Size by Country
  11. 8.4.1 Europe In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe In-Vitro Diagnostics Market Size by Country (2021-2026)
  13. 8.4.3 Europe In-Vitro Diagnostics Market Size by Country (2027-2032)
  14. 8.4.4 Europe In-Vitro Diagnostics Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China In-Vitro Diagnostics Market Size (2021-2032)
  2. 9.2 China In-Vitro Diagnostics Market Size by Type
  3. 9.2.1 China In-Vitro Diagnostics Market Size by Type (2021-2026)
  4. 9.2.2 China In-Vitro Diagnostics Market Size by Type (2027-2032)
  5. 9.2.3 China In-Vitro Diagnostics Market Share by Type (2021-2032)
  6. 9.3 China In-Vitro Diagnostics Market Size by Application
  7. 9.3.1 China In-Vitro Diagnostics Market Size by Application (2021-2026)
  8. 9.3.2 China In-Vitro Diagnostics Market Size by Application (2027-2032)
  9. 9.3.3 China In-Vitro Diagnostics Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia In-Vitro Diagnostics Market Size (2021-2032)
  2. 10.2 Asia In-Vitro Diagnostics Market Size by Type
  3. 10.2.1 Asia In-Vitro Diagnostics Market Size by Type (2021-2026)
  4. 10.2.2 Asia In-Vitro Diagnostics Market Size by Type (2027-2032)
  5. 10.2.3 Asia In-Vitro Diagnostics Market Share by Type (2021-2032)
  6. 10.3 Asia In-Vitro Diagnostics Market Size by Application
  7. 10.3.1 Asia In-Vitro Diagnostics Market Size by Application (2021-2026)
  8. 10.3.2 Asia In-Vitro Diagnostics Market Size by Application (2027-2032)
  9. 10.3.3 Asia In-Vitro Diagnostics Market Share by Application (2021-2032)
  10. 10.4 Asia In-Vitro Diagnostics Market Size by Country
  11. 10.4.1 Asia In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia In-Vitro Diagnostics Market Size by Country (2021-2026)
  13. 10.4.3 Asia In-Vitro Diagnostics Market Size by Country (2027-2032)
  14. 10.4.4 Asia In-Vitro Diagnostics Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa In-Vitro Diagnostics Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Type
  3. 11.2.1 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa In-Vitro Diagnostics Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Application
  7. 11.3.1 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa In-Vitro Diagnostics Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country
  11. 11.4.1 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa In-Vitro Diagnostics Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa In-Vitro Diagnostics Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst